NanJing Pharmaceutical Company Limited announced earnings results for the first quarter ended March 31, 2021. For the first quarter, the company announced sales was CNY 11,084.756 million compared to CNY 8,789.021 million a year ago. Operating income was CNY 162.109 million compared to CNY 128.704 million a year ago. Net income was CNY 101.956 million compared to CNY 75.959 million a year ago. Basic earnings per share from continuing operations was CNY 0.098 compared to CNY 0.073 a year ago.